277 related articles for article (PubMed ID: 23643146)
1. Altered synapses and gliotransmission in Alzheimer's disease and AD model mice.
Mitew S; Kirkcaldie MT; Dickson TC; Vickers JC
Neurobiol Aging; 2013 Oct; 34(10):2341-51. PubMed ID: 23643146
[TBL] [Abstract][Full Text] [Related]
2. Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease.
Canas PM; Simões AP; Rodrigues RJ; Cunha RA
Neuropharmacology; 2014 Jan; 76 Pt A():51-6. PubMed ID: 24029236
[TBL] [Abstract][Full Text] [Related]
3. Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.
Sokolow S; Luu SH; Nandy K; Miller CA; Vinters HV; Poon WW; Gylys KH
Neurobiol Dis; 2012 Jan; 45(1):381-7. PubMed ID: 21914482
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease.
Amorim JA; Canas PM; Tomé AR; Rolo AP; Agostinho P; Palmeira CM; Cunha RA
J Alzheimers Dis; 2017; 60(2):525-536. PubMed ID: 28869472
[TBL] [Abstract][Full Text] [Related]
5. Cerebral level of vGlut1 is increased and level of glycine is decreased in TgSwDI mice.
Timmer NM; Metaxas A; van der Stelt I; Kluijtmans LA; van Berckel BN; Verbeek MM
J Alzheimers Dis; 2014; 39(1):89-101. PubMed ID: 24145381
[TBL] [Abstract][Full Text] [Related]
6. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
Willén K; Sroka A; Takahashi RH; Gouras GK
J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
[TBL] [Abstract][Full Text] [Related]
8. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
Minkeviciene R; Ihalainen J; Malm T; Matilainen O; Keksa-Goldsteine V; Goldsteins G; Iivonen H; Leguit N; Glennon J; Koistinaho J; Banerjee P; Tanila H
J Neurochem; 2008 May; 105(3):584-94. PubMed ID: 18042177
[TBL] [Abstract][Full Text] [Related]
9. Region- and age-specific changes in glutamate transport in the AβPP23 mouse model for Alzheimer's disease.
Schallier A; Smolders I; Van Dam D; Loyens E; De Deyn PP; Michotte A; Michotte Y; Massie A
J Alzheimers Dis; 2011; 24(2):287-300. PubMed ID: 21297271
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model.
Krantic S; Isorce N; Mechawar N; Davoli MA; Vignault E; Albuquerque M; Chabot JG; Moyse E; Chauvin JP; Aubert I; McLaurin J; Quirion R
J Alzheimers Dis; 2012; 29(2):293-308. PubMed ID: 22232004
[TBL] [Abstract][Full Text] [Related]
11. Effects of amyloid-β plaque proximity on the axon initial segment of pyramidal cells.
León-Espinosa G; DeFelipe J; Muñoz A
J Alzheimers Dis; 2012; 29(4):841-52. PubMed ID: 22337828
[TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone ameliorates hippocampal synapse loss by inhibiting microglial/macrophages activation in glial glutamate transporter-1 dependent manner in the APP/PS1 mouse model of Alzheimer's disease.
Liu LZ; Fan SJ; Gao JX; Li WB; Xian XH
Brain Res Bull; 2023 Aug; 200():110683. PubMed ID: 37301482
[TBL] [Abstract][Full Text] [Related]
13. The impact of Abeta-plaques on cortical cholinergic and non-cholinergic presynaptic boutons in alzheimer's disease-like transgenic mice.
Hu L; Wong TP; Côté SL; Bell KF; Cuello AC
Neuroscience; 2003; 121(2):421-32. PubMed ID: 14522000
[TBL] [Abstract][Full Text] [Related]
14. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
[TBL] [Abstract][Full Text] [Related]
15. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H
Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754
[TBL] [Abstract][Full Text] [Related]
16. Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice.
Boncristiano S; Calhoun ME; Howard V; Bondolfi L; Kaeser SA; Wiederhold KH; Staufenbiel M; Jucker M
Neurobiol Aging; 2005 May; 26(5):607-13. PubMed ID: 15708435
[TBL] [Abstract][Full Text] [Related]
17. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
Duffy AM; Hölscher C
Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
[TBL] [Abstract][Full Text] [Related]
18. Increased vulnerability to depressive-like behavior of mice with decreased expression of VGLUT1.
Garcia-Garcia AL; Elizalde N; Matrov D; Harro J; Wojcik SM; Venzala E; Ramírez MJ; Del Rio J; Tordera RM
Biol Psychiatry; 2009 Aug; 66(3):275-82. PubMed ID: 19409534
[TBL] [Abstract][Full Text] [Related]
19. Repeat propofol anesthesia does not exacerbate plaque deposition or synapse loss in APP/PS1 Alzheimer's disease mice.
Woodhouse A; Fernandez-Martos CM; Atkinson RAK; Hanson KA; Collins JM; O'Mara AR; Terblanche N; Skinner MW; Vickers JC; King AE
BMC Anesthesiol; 2018 Apr; 18(1):47. PubMed ID: 29699479
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease.
Rodriguez-Perdigon M; Tordera RM; Gil-Bea FJ; Gerenu G; Ramirez MJ; Solas M
Hippocampus; 2016 Oct; 26(10):1303-12. PubMed ID: 27258819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
